
Total amount raised
$49.7 Million
Latest funding date
5/1/2003

Location
Fast Track has successfully raised funding over three rounds, with the latest being a Series D round. The company is backed by 11 investors, including W Capital Partners and Frazier & Associates.
Keep reading to explore the intricacies of Fast Track's fundraising journey and the investors backing this innovative platform.
What Is Fast Track?
Fast Track is an information technology company focused on improving and expediting the clinical trials process. It operates in the Clinical Trials, Health Care, and Information Technology industries. The company is located in San Mateo, California, United States, and has an employee count of 1-10.
Fast Track has been acquired by Medidata, a leading provider of SaaS and data analytics solutions for clinical research. The acquisition has allowed Fast Track to leverage Medidata's unified platform to further streamline workflows and accelerate clinical trials.
How Much Funding Has Fast Track Raised?
- Series B
- Amount Raised: USD 15,600,000
- Date: April 2000
- Lead Investors: Tredegar Investments
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the company's market presence and enhance product development.
- Series C
- Amount Raised: USD 30,100,000
- Date: April 2001
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To accelerate market rollout and product development.
- Series D
- Amount Raised: USD 3,967,000
- Date: May 2003
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further streamline workflows and accelerate clinical trials.
Total Amount Raised: USD 49,667,000. Current Valuation: Not publicly disclosed.
Key Investors
Here are the major investors in Fast Track:
- W Capital Partners
- Details: W Capital Partners is a private equity firm that specializes in providing liquidity solutions to private equity investors and growth capital to companies. They focus on secondary direct investments.
- Investment Focus Areas: Technology, Healthcare, Consumer.
- Notable Investments: Not publicly disclosed.
- Frazier & Associates
- Details: Frazier & Associates is a venture capital firm that invests in healthcare companies. They have a long history of supporting innovative healthcare solutions.
- Investment Focus Areas: Healthcare, Biotechnology, Medical Devices.
- Notable Investments: Not publicly disclosed.
- Tredegar Investments
- Details: Tredegar Investments is a private investment firm. They are known for their strategic investments in various sectors.
- Investment Focus Areas: Not publicly disclosed.
- Notable Investments: Not publicly disclosed.
What's Next for Fast Track?
Unfortunately, the provided sources do not contain any specific information about the opportunities, future fundraising, industry trends, or challenges related to Fast Track. Therefore, I am unable to fulfill the request to write a section based on these sources.
The sources either contain no relevant information or are placeholder pages without any content related to Fast Track. As a result, I cannot provide a narrative around the future of Fast Track based on the given data.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Fast Track and gather other critical business insights.
Sign up for free to start making data-driven decisions and stay ahead in the competitive market.


















